Stock Taper Q4 Revenue: $582,000; Total Revenue FY 2026: $4.5 million, slightly down from $4.7 million in FY 2025.
Net Loss: Q4 net loss of $4 million ($0.22 per share); FY 2026 net loss of $9.2 million ($0.52 per share), compared to $3 million ($0.23 per share) in FY 2025.
Adjusted Net Loss: Q4 adjusted net loss of $2.7 million ($0.15 per share); FY 2026 adjusted net loss of $4.6 million ($0.26 per share), up from $116,000 ($0.01 per share) in FY 2025.
Adjusted EBITDA: Negative $2.9 million for Q4 and negative $5.2 million for FY 2026, a decline from positive adjusted EBITDA of $186,000 in FY 2025.
Cash Position: $56 million in cash and cash equivalents at the end of Q4, up from $37.8 million in Q3 and $15.7 million a year prior.
Aeluma is focusing on the AI datacom market, emphasizing the development of high-speed photodetectors and quantum dot lasers.
The company has successfully transitioned a Navy program into a second phase, enhancing its photodetector technology.
Aeluma is expanding its workforce, now over 30 employees, and has appointed key personnel to drive product development and commercialization.
A strategic agreement with Sumitomo Chemical Advanced Technologies aims to increase wafer production capacity.
The company is negotiating a letter of intent for up to $30 million in funding from the Department of Commerce's CHIPS R&D Office, which is expected to support commercialization efforts.
Aeluma anticipates recognizing approximately $2.3 million in government contract revenue in FY 2027, with potential for an additional $2 million from ongoing discussions.
The company is shifting focus from government contracts to commercial revenue opportunities, particularly in the AI datacom sector.
Expected capital expenditures for FY 2027 are projected to be between $10 million and $12 million, primarily for MOCVD reactors to enhance manufacturing capabilities.
The net loss and adjusted EBITDA have significantly increased compared to the previous year, raising concerns about operational efficiency and cost management.
Revenue has plateaued, with no growth from government contracts, indicating potential reliance on future commercial agreements.
The company faces challenges in transitioning from government funding to commercial revenue, which may impact short-term financial performance.
Management confirmed that the near-term focus remains on the AI datacom market, with other markets like mobile being secondary.
Discussions regarding non-recurring engineering (NRE) contracts are primarily within the AI datacom sector, reflecting urgency due to supply chain constraints.
The transition to new data center architectures (NPO, CPO) is seen as an opportunity for Aeluma, as it may require customized solutions that leverage their technology.
The potential CHIPS funding is expected to be treated as an equity investment rather than traditional revenue, which could affect financial reporting. Overall, Aeluma is positioned for growth in the AI datacom market but faces challenges in achieving immediate revenue growth and managing operational losses. The strategic focus on commercialization and partnerships is critical for future success.
SOURCE: Q4 2026 EARNINGS CALL TRANSCRIPT